You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三生國健(688336.SH)及全資子公司丹生醫藥擬與瀋陽三生簽署《許可協議》
格隆匯 02-19 17:59

格隆匯2月19日丨三生國健(688336.SH)公佈,公司及全資子公司丹生醫藥擬與瀋陽三生簽署《許可協議》,將公司612項目和708項目獨家授予給瀋陽三生。瀋陽三生可以在許可區域內(中國大陸地區)利用許可專利、許可技術祕密以及三生國健許可瀋陽三生使用的其他知識產權,針對合作靶點就所有適應症對許可產品進行研發、註冊、改進、生產、使用、銷售、許諾銷售、出口和進口。

本次交易對價包括首付款10,190.00萬元,里程碑付款及後續權利金,即任何一款許可產品在許可區域內首次上市銷售後,瀋陽三生應就該許可產品在許可區域內產生的淨銷售額,向三生國健支付權利金,權利金金額爲該款許可產品的淨銷售額*15%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account